Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic fluorination process enhances purity and yield for pharmaceutical intermediates manufacturing ensuring supply chain stability and cost efficiency.
Patent CN113831242A reveals a room-temperature synthesis route for Dolutegravir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel Lewis acid catalyzed route ensures >99.9% purity and scalable production for global pharmaceutical supply chains seeking cost efficiency.
Patent CN110467585A introduces a mild visible light method for benzothiazole derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107522585B details a mild transfer hydrogenation method for quinoline resolution. Achieves 99% ee with organocatalysis, offering cost-effective and scalable chiral intermediate manufacturing.
Patent CN114736315B details a novel one-pot synthesis for lentinan core fragments. This route eliminates toxic allyl protection, offering cost reduction in API manufacturing and reliable supply.
Patent CN108299482A details a novel nucleophilic fluorination method for F-BPA, offering high specific activity and cost reduction in radiopharmaceutical manufacturing for PET imaging.
Patent CN110283800A details a novel enzymatic route for α-ketoglutarate. Discover cost reduction in nutritional ingredients manufacturing and high-purity supply chain advantages.
Patent CN114805259A details a robust Ni@Al2O3 catalyst for furfurylamine production, offering superior stability and selectivity over conventional noble metal methods.
Patent CN1628087A reveals a novel onium salt catalyzed route for alkenone synthesis, offering superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105712854B reveals efficient Ir-catalyzed biomass conversion. Achieve high purity and cost reduction in fine chemical manufacturing with scalable aqueous processes.
Novel metal oxide catalyzed production method ensures high purity thiazolidine intermediate with reduced corrosion and scalable manufacturing for global agrochemical supply chains.
Novel one-pot method for high-purity hexaphenoxy cyclotriphosphazene. Reduces cost and time for halogen-free flame retardant manufacturing.
Patent CN100343240C reveals an inorganic base-catalyzed method for high-purity CCR5 antagonist intermediates, offering significant cost reduction and supply chain reliability.
Patent CN112094205A reveals a safer liquid-phase synthesis for Fmoc-Ser(tBu)-OH, offering high chiral purity and cost reduction in pharmaceutical intermediate manufacturing.
Discover the novel one-step catalytic oxidation route for 4,4,5,5,5-pentafluoropentanol. Enhanced yield, reduced waste, and reliable supply for pharmaceutical intermediates.
Patent CN105367465A reveals a high-yield Cu-Ni catalyzed synthesis for pharmaceutical intermediates, offering significant supply chain and cost advantages.
Patent CN103497147B details a mild Yb(OTf)3 catalyzed route for 1,4-dihydropyridines. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN116854051B reveals efficient deep eutectic solvent method. High purity LiFSI intermediate with mild conditions and supply chain advantages.
Patent CN103524308B reveals solid acid catalysis for high-purity halogenated phenol manufacturing with reduced waste and enhanced supply chain reliability.